Fresenius Medical Care AG
FMS· NYSE
Source filing unavailable
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | €5.07B | €5.08B | €4.99B | €5.00B |
| Net Income | €327.08M | €66.90M | €187.93M | €138.80M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR